TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.7316$ -9.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACTU
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
100.0% 100.0% 98.8% 97.2%
99.8% 98.8% 92.7% 93.8%
99.8% 98.8% 92.7% 93.8%
27.6% 3,425.8% 98.9% 43.5%
21.2% 231.0% 94.5% 40.7%
10.4% 114.2% 20.6% 10.9%
72.4% -3,325.8% 1.1% 56.5%
-392.3% -3,508.3% -1,420.6% -1,101.5%
73.4% 501.9% 209.4% 149.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?